USE OF ANTI-AGING GLYCOPEPTIDES FOR TREATMENT OF DRY EYE DISEASE, RETINAL DEGENERATIVE DISEASES, OR OCCULAR INFLAMMATION

摘要

The present document describes methods of using a gem-difluorinated C-glycopeptide compound of general formula I, or a pharmaceutically acceptable base, addition salt with an acid, hydrate or solvate of the compound of general formula I for the treatment or prevention of dry eye disease in a subject in need thereof and/or for the treatment or prevention of a retinal degenerative disease, an ocular inflammation, or a combination thereof.